http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105267231-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2015-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105267231-B |
| titleOfInvention | Application of the L ascorbyls glucoside compound in α glucosidase inhibitors are prepared |
| abstract | The present invention relates to L ascorbyl glucoside compounds, such as 2 O β D glucosyl group L ascorbic acid, 3 O β D glucosyl group L ascorbic acid and 2 O β D galactosyl L ascorbic acid, the application in α glucosidase inhibitors are prepared.Such compound has significant inhibitory activity to α glucuroides, and effect can be used as α glucosidase inhibitor development and application close to voglibose. |
| priorityDate | 2015-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 116.